{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T05:35:06Z","timestamp":1773293706626,"version":"3.50.1"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2017,10,5]],"date-time":"2017-10-05T00:00:00Z","timestamp":1507161600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Child Adolesc Psychiatry"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1007\/s00787-017-1061-4","type":"journal-article","created":{"date-parts":[[2017,10,5]],"date-time":"2017-10-05T12:49:01Z","timestamp":1507207741000},"page":"367-376","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Clinical factors associated with decision to recommend methylphenidate treatment for children with ADHD in France"],"prefix":"10.1007","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5463-7539","authenticated-orcid":false,"given":"Elodie","family":"Courtabessis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florence","family":"Pupier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurie","family":"Surig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie-Christine","family":"Picot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erika","family":"Nogu\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Val\u00e9rie","family":"Macioce","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"Stein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diane","family":"Purper-Ouakil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,10,5]]},"reference":[{"key":"1061_CR1","volume-title":"Canadian ADHD practice guidelines","author":"Canadian Attention Deficit Hyperactivity Disorder Resource Alliance (CADDRA)","year":"2011","unstructured":"Canadian Attention Deficit Hyperactivity Disorder Resource Alliance (CADDRA) (2011) Canadian ADHD practice guidelines, 3rd edn, CADDRA, Toronto ON","edition":"3"},{"key":"1061_CR2","doi-asserted-by":"publisher","first-page":"2190","DOI":"10.1016\/S0140-6736(14)61684-6","volume":"385","author":"S Dalsgaard","year":"2015","unstructured":"Dalsgaard S, \u00d8stergaard SD, Leckman JF et al (2015) Mortality in children, adolescents, and adults with attention deficit hyperactivity disorder: a nationwide cohort study. Lancet 385:2190\u20132196. doi: 10.1016\/S0140-6736(14)61684-6","journal-title":"Lancet"},{"issue":"Suppl 1","key":"1061_CR3","doi-asserted-by":"crossref","first-page":"I4","DOI":"10.1007\/s00787-006-1002-0","volume":"15","author":"U Preuss","year":"2006","unstructured":"Preuss U, Ralston SJ, Baldursson G et al (2006) Study design, baseline patient characteristics and intervention in a cross-cultural framework: results from the ADORE study. Eur Child Adolesc Psychiatry 15(Suppl 1):I4\u201314","journal-title":"Eur Child Adolesc Psychiatry"},{"key":"1061_CR4","first-page":"A52","volume":"3","author":"TW Strine","year":"2006","unstructured":"Strine TW, Lesesne CA, Okoro CA et al (2006) Emotional and behavioral difficulties and impairments in everyday functioning among children with a history of attention-deficit\/hyperactivity disorder. Prev Chronic Dis 3:A52","journal-title":"Prev Chronic Dis"},{"key":"1061_CR5","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1542\/peds.2011-2654","volume":"128","author":"American Academy of Pediatrics","year":"2011","unstructured":"American Academy of Pediatrics (2011) ADHD: clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit\/hyperactivity disorder in children and adolescents. Pediatrics 128:1007\u20131022. doi: 10.1542\/peds.2011-2654","journal-title":"Pediatrics"},{"key":"1061_CR6","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1177\/0269881113519509","volume":"28","author":"B Bolea-Alama\u00f1ac","year":"2014","unstructured":"Bolea-Alama\u00f1ac B, Nutt DJ, Adamou M et al (2014) Evidence-based guidelines for the pharmacological management of attention deficit hyperactivity disorder: update on recommendations from the British Association for Psychopharmacology. J Psychopharmacol (Oxf) 28:179\u2013203","journal-title":"J Psychopharmacol (Oxf)"},{"key":"1061_CR7","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.neurenf.2011.10.009","volume":"60","author":"E Acquaviva","year":"2012","unstructured":"Acquaviva E, Peyre H, Falissard B (2012) Panorama de la prescription et de la consommation des psychotropes chez l\u2019enfant et l\u2019adolescent en France. Neuropsychiatr Enfance Adolesc 60:77\u201385","journal-title":"Neuropsychiatr Enfance Adolesc"},{"key":"1061_CR8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta13060","volume":"13","author":"ICK Wong","year":"2009","unstructured":"Wong ICK, Asherson P, Bilbow A et al (2009) Cessation of attention deficit hyperactivity disorder drugs in the young (CADDY)\u2014a pharmacoepidemiological and qualitative study. Health Technol Assess Winch Engl 13:1\u2013120 (iii\u2013iv, ix\u2013xi)","journal-title":"Health Technol Assess Winch Engl"},{"key":"1061_CR9","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1753-2000-2-26","volume":"2","author":"JM Zito","year":"2008","unstructured":"Zito JM, Safer DJ, de Berg LT, den J et al (2008) A three-country comparison of psychotropic medication prevalence in youth. Child Adolesc Psychiatry Ment Health 2:26","journal-title":"Child Adolesc Psychiatry Ment Health"},{"key":"1061_CR10","unstructured":"Institut national de la sant\u00e9 et de la recherche m\u00e9dicale (Inserm) (2012) M\u00e9dicaments psychotropes: consommations et pharmacod\u00e9pendances. Synth\u00e8se et recommandations. Les \u00e9ditions Inserm. ISBN 978-2-85598-892-6"},{"key":"1061_CR11","unstructured":"Agence nationale de s\u00e9crurit\u00e9 du m\u00e9dicament et des produits de sant\u00e9 (ANSM) (2013) M\u00e9thylph\u00e9nidate: donn\u00e9es d\u2019utilisation et de s\u00e9curit\u00e9 d\u2019emploi en France. http:\/\/ansm.sante.fr\/"},{"key":"1061_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/s12888-017-1222-5","author":"CL Hall","year":"2017","unstructured":"Hall CL, Valentine AZ, Walker GM et al (2017) Study of user experience of an objective test (QbTest) to aid ADHD assessment and medication management: a multi-methods approach. BMC Psychiatry. doi: 10.1186\/s12888-017-1222-5","journal-title":"BMC Psychiatry"},{"issue":"Suppl 1","key":"1061_CR13","first-page":"I7","volume":"13","author":"E Taylor","year":"2004","unstructured":"Taylor E, D\u00f6pfner M, Sergeant J et al (2004) European clinical guidelines for hyperkinetic disorder\u2014first upgrade. Eur Child Adolesc Psychiatry 13(Suppl 1):I7\u201330","journal-title":"Eur Child Adolesc Psychiatry"},{"key":"1061_CR14","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s00787-011-0235-8","volume":"21","author":"H Kovshoff","year":"2012","unstructured":"Kovshoff H, Williams S, Vrijens M et al (2012) The decisions regarding ADHD management (DRAMa) study: uncertainties and complexities in assessment, diagnosis and treatment, from the clinician\u2019s point of view. Eur Child Adolesc Psychiatry 21:87\u201399. doi: 10.1007\/s00787-011-0235-8","journal-title":"Eur Child Adolesc Psychiatry"},{"key":"1061_CR15","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1111\/j.1600-0447.2011.01737.x","volume":"124","author":"D Bhugra","year":"2011","unstructured":"Bhugra D, Easter A, Mallaris Y, Gupta S (2011) Clinical decision making in psychiatry by psychiatrists: clinical decision making in psychiatrists. Acta Psychiatr Scand 124:403\u2013411. doi: 10.1111\/j.1600-0447.2011.01737.x","journal-title":"Acta Psychiatr Scand"},{"key":"1061_CR16","unstructured":"Haute Autorit\u00e9 de Sant\u00e9 (2014) Recommandation de bonne pratique. Conduite \u00e0 tenir en m\u00e9decine de premier recours devant un enfant ou un adolescent susceptible d\u2019avoir un trouble d\u00e9ficit de l\u2019attention avec ou sans hyperactivit\u00e9"},{"key":"1061_CR17","volume-title":"Attention deficit hyperactivity disorder: diagnosis and management of ADHD in children, young people and adults","author":"NICE","year":"2008","unstructured":"NICE (2008) Attention deficit hyperactivity disorder: diagnosis and management of ADHD in children, young people and adults. British Psychological Society (UK), Leicester"},{"key":"1061_CR18","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1007\/s00787-006-0549-0","volume":"15","author":"T Banaschewski","year":"2006","unstructured":"Banaschewski T, Coghill D, Santosh P et al (2006) Long-acting medications for the hyperkinetic disorders. A systematic review and European treatment guideline. Eur Child Adolesc Psychiatry 15:476\u2013495. doi: 10.1007\/s00787-006-0549-0","journal-title":"Eur Child Adolesc Psychiatry"},{"key":"1061_CR19","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1007\/s00787-016-0845-2","volume":"25","author":"PJ Hoekstra","year":"2016","unstructured":"Hoekstra PJ, Buitelaar JK (2016) Is the evidence base of methylphenidate for children and adolescents with attention-deficit\/hyperactivity disorder flawed? Eur Child Adolesc Psychiatry 25:339\u2013340. doi: 10.1007\/s00787-016-0845-2","journal-title":"Eur Child Adolesc Psychiatry"},{"key":"1061_CR20","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1089\/cap.2008.096","volume":"19","author":"C-Y Chen","year":"2009","unstructured":"Chen C-Y, Gerhard T, Winterstein AG (2009) Determinants of initial pharmacological treatment for youths with attention-deficit\/hyperactivity disorder. J Child Adolesc Psychopharmacol 19:187\u2013195. doi: 10.1089\/cap.2008.096","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"1061_CR21","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1177\/1087054709347173","volume":"14","author":"B Falissard","year":"2010","unstructured":"Falissard B, Coghill D, Rothenberger A et al (2010) Short-term effectiveness of medication and psychosocial intervention in a cohort of newly diagnosed patients with inattention, impulsivity, and hyperactivity problems. J Atten Disord 14:147\u2013156. doi: 10.1177\/1087054709347173","journal-title":"J Atten Disord"},{"key":"1061_CR22","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1186\/s12888-014-0304-x","volume":"14","author":"J Hong","year":"2014","unstructured":"Hong J, Novick D, Treuer T et al (2014) Patient characteristics associated with treatment initiation among paediatric patients with attention-deficit\/hyperactivity disorder symptoms in a naturalistic setting in Central Europe and East Asia. BMC Psychiatry 14:304","journal-title":"BMC Psychiatry"},{"key":"1061_CR23","volume-title":"Kiddie-SADS-version vie entiere (K-SADS-PL) (R\u00e9vis\u00e9e Modif, edn)","author":"MC Mouren-Sim\u00e9oni","year":"2002","unstructured":"Mouren-Sim\u00e9oni MC, Cook S, Flament M et al (2002) Kiddie-SADS-version vie entiere (K-SADS-PL) (R\u00e9vis\u00e9e Modif, edn). INSERM, Paris"},{"key":"1061_CR24","volume-title":"ADHD rating scale-IV: checklists, norms, and clinical interpretation","author":"DuPaul Gj","year":"1998","unstructured":"Gj DuPaul, Power TJ, Anastopoulos AD, Reid R (1998) ADHD rating scale-IV: checklists, norms, and clinical interpretation. Guilford, New York"},{"key":"1061_CR25","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1097\/00004583-200111000-00015","volume":"40","author":"R Goodman","year":"2001","unstructured":"Goodman R (2001) Psychometric properties of the strengths and difficulties questionnaire. J Am Acad Child Adolesc Psychiatry 40:1337\u20131345","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"1061_CR26","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1111\/1469-7610.00806","volume":"42","author":"T Manly","year":"2001","unstructured":"Manly T, Anderson V, Nimmo-Smith I et al (2001) The differential assessment of children\u2019s attention: the test of everyday attention for children (TEA-Ch), normative sample and ADHD performance. J Child Psychol Psychiatry 42:1065\u20131081","journal-title":"J Child Psychol Psychiatry"},{"key":"1061_CR27","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s13034-015-0083-2","volume":"9","author":"D Coghill","year":"2015","unstructured":"Coghill D, Seth S (2015) Effective management of attention-deficit\/hyperactivity disorder (ADHD) through structured re-assessment: the Dundee ADHD Clinical Care Pathway. Child Adolesc Psychiatry Ment Health 9:52. doi: 10.1186\/s13034-015-0083-2","journal-title":"Child Adolesc Psychiatry Ment Health"},{"key":"1061_CR28","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.cnr.2005.09.010","volume":"5","author":"PJ Santosh","year":"2005","unstructured":"Santosh PJ, Taylor E, Swanson J et al (2005) Refining the diagnoses of inattention and overactivity syndromes: a reanalysis of the multimodal treatment study of attention deficit hyperactivity disorder (ADHD) based on ICD-10 criteria for hyperkinetic disorder. Clin Neurosci Res 5:307\u2013314. doi: 10.1016\/j.cnr.2005.09.010","journal-title":"Clin Neurosci Res"},{"key":"1061_CR29","first-page":"90","volume":"16","author":"R Schachar","year":"2007","unstructured":"Schachar R, Chen S, Crosbie J et al (2007) Comparison of the predictive validity of hyperkinetic disorder and attention deficit hyperactivity disorder. J Can Acad Child Adolesc Psychiatry (J Acad Can Psychiatr Enfant Adolesc) 16:90\u2013100","journal-title":"J Can Acad Child Adolesc Psychiatry (J Acad Can Psychiatr Enfant Adolesc)"},{"key":"1061_CR30","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1097\/00004583-200102000-00009","volume":"40","author":"PS Jensen","year":"2001","unstructured":"Jensen PS, Hinshaw SP, Kraemer HC et al (2001) ADHD comorbidity findings from the MTA study: comparing comorbid subgroups. J Am Acad Child Adolesc Psychiatry 40:147\u2013158. doi: 10.1097\/00004583-200102000-00009","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"1061_CR31","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1097\/CHI.0b013e31819c23d0","volume":"48","author":"BSG Molina","year":"2009","unstructured":"Molina BSG, Hinshaw SP, Swanson JM et al (2009) The MTA at 8\u00a0years: prospective follow-up of children treated for combined-type ADHD in a multisite study. J Am Acad Child Adolesc Psychiatry 48:484\u2013500. doi: 10.1097\/CHI.0b013e31819c23d0","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"1061_CR32","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1177\/070674371506000202","volume":"60","author":"T Pringsheim","year":"2015","unstructured":"Pringsheim T, Hirsch L, Gardner D, Gorman DA (2015) The pharmacological management of oppositional behaviour, conduct problems, and aggression in children and adolescents with attention-deficit hyperactivity disorder, oppositional defiant disorder, and conduct disorder: a systematic review and meta-analysis. Part 1: Psychostimulants, alpha-2 agonists, and atomoxetine. Can J Psychiatry Rev Can Psychiatr 60:42\u201351","journal-title":"Can J Psychiatry Rev Can Psychiatr"},{"key":"1061_CR33","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1177\/070674371506000204","volume":"60","author":"DA Gorman","year":"2015","unstructured":"Gorman DA, Gardner DM, Murphy AL et al (2015) Canadian guidelines on pharmacotherapy for disruptive and aggressive behaviour in children and adolescents with attention-deficit hyperactivity disorder, oppositional defiant disorder, or conduct disorder. Can J Psychiatry Rev Can Psychiatr 60:62\u201376","journal-title":"Can J Psychiatry Rev Can Psychiatr"},{"key":"1061_CR34","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1111\/j.1475-3588.2009.00538.x","volume":"15","author":"EA Fliers","year":"2009","unstructured":"Fliers EA, Franke B, Lambregts-Rommelse NNJ et al (2009) Undertreatment of motor problems in children with ADHD. Child Adolesc Ment Health 15:85\u201390. doi: 10.1111\/j.1475-3588.2009.00538.x","journal-title":"Child Adolesc Ment Health"},{"key":"1061_CR35","doi-asserted-by":"publisher","first-page":"i80","DOI":"10.1007\/s00787-004-1008-4","volume":"13","author":"C Gillberg","year":"2004","unstructured":"Gillberg C, Gillberg IC, Rasmussen P et al (2004) Co-existing disorders in ADHD\u2014implications for diagnosis and intervention. Eur Child Adolesc Psychiatry 13:i80\u2013i92. doi: 10.1007\/s00787-004-1008-4","journal-title":"Eur Child Adolesc Psychiatry"},{"key":"1061_CR36","doi-asserted-by":"publisher","first-page":"2080","DOI":"10.1016\/j.ridd.2012.06.003","volume":"33","author":"M Brossard-Racine","year":"2012","unstructured":"Brossard-Racine M, Shevell M, Snider L et al (2012) Motor skills of children newly diagnosed with attention deficit hyperactivity disorder prior to and following treatment with stimulant medication. Res Dev Disabil 33:2080\u20132087. doi: 10.1016\/j.ridd.2012.06.003","journal-title":"Res Dev Disabil"},{"key":"1061_CR37","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.ridd.2014.09.023","volume":"36C","author":"M-L Kaiser","year":"2014","unstructured":"Kaiser M-L, Schoemaker MM, Albaret J-M, Geuze RH (2014) What is the evidence of impaired motor skills and motor control among children with attention deficit hyperactivity disorder (ADHD)? Systematic review of the literature. Res Dev Disabil 36C:338\u2013357. doi: 10.1016\/j.ridd.2014.09.023","journal-title":"Res Dev Disabil"},{"key":"1061_CR38","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1177\/1087054711428806","volume":"17","author":"NS Thaler","year":"2013","unstructured":"Thaler NS, Bello DT, Etcoff LM (2013) WISC-IV profiles are associated with differences in symptomatology and outcome in children with ADHD. J Atten Disord 17:291\u2013301","journal-title":"J Atten Disord"},{"key":"1061_CR39","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/j.acn.2008.03.007","volume":"23","author":"RCK Chan","year":"2008","unstructured":"Chan RCK, Wang L, Ye J et al (2008) A psychometric study of the test of everyday attention for children in the Chinese setting. Arch Clin Neuropsychol Off J Natl Acad Neuropsychol 23:455\u2013466. doi: 10.1016\/j.acn.2008.03.007","journal-title":"Arch Clin Neuropsychol Off J Natl Acad Neuropsychol"},{"key":"1061_CR40","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1097\/chi.0b013e318054e724","volume":"46","author":"S Pliszka","year":"2007","unstructured":"Pliszka S, AACAP Work Group on Quality Issues (2007) Practice parameter for the assessment and treatment of children and adolescents with attention-deficit\/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 46:894\u2013921. doi: 10.1097\/chi.0b013e318054e724","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"1061_CR41","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1093\/jpepsy\/jsl055","volume":"32","author":"SP Hinshaw","year":"2007","unstructured":"Hinshaw SP (2007) Moderators and mediators of treatment outcome for youth with ADHD: understanding for whom and how interventions work. J Pediatr Psychol 32:664\u2013675","journal-title":"J Pediatr Psychol"},{"key":"1061_CR42","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1001\/archpsyc.56.12.1088","volume":"56","author":"The MTA Cooperative Group","year":"1999","unstructured":"The MTA Cooperative Group (1999) Moderators and mediators of treatment response for children with attention-deficit\/hyperactivity disorder: the multimodal treatment study of children with attention-deficit\/hyperactivity disorder. Arch Gen Psychiatry 56:1088\u20131096","journal-title":"Arch Gen Psychiatry"},{"key":"1061_CR43","doi-asserted-by":"publisher","DOI":"10.1007\/s12402-014-0143-0","author":"J Setyawan","year":"2014","unstructured":"Setyawan J, Fridman M, Hodgkins P et al (2014) Relationship between symptom impairment and treatment outcome in children and adolescents with attention-deficit\/hyperactivity disorder: a physician perspective. Atten Deficit Hyperact Disord. doi: 10.1007\/s12402-014-0143-0","journal-title":"Atten Deficit Hyperact Disord"},{"key":"1061_CR44","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1007\/s00787-013-0393-y","volume":"22","author":"H Kovshoff","year":"2013","unstructured":"Kovshoff H, Vrijens M, Thompson M et al (2013) What influences clinicians\u2019 decisions about ADHD medication? Initial data from the Influences on Prescribing for ADHD Questionnaire (IPAQ). Eur Child Adolesc Psychiatry 22:533\u2013542. doi: 10.1007\/s00787-013-0393-y","journal-title":"Eur Child Adolesc Psychiatry"},{"key":"1061_CR45","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1111\/cch.12036","volume":"40","author":"S-J Chow","year":"2014","unstructured":"Chow S-J, Sciberras E, Gillam LH et al (2014) Paediatricians\u2019 decision making about prescribing stimulant medications for children with attention-deficit\/hyperactivity disorder: paediatricians\u2019 decision making in ADHD. Child Care Health Dev 40:301\u2013308. doi: 10.1111\/cch.12036","journal-title":"Child Care Health Dev"}],"container-title":["European Child & Adolescent Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00787-017-1061-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00787-017-1061-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00787-017-1061-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,18]],"date-time":"2020-10-18T20:07:59Z","timestamp":1603051679000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00787-017-1061-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,5]]},"references-count":45,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["1061"],"URL":"https:\/\/doi.org\/10.1007\/s00787-017-1061-4","relation":{},"ISSN":["1018-8827","1435-165X"],"issn-type":[{"value":"1018-8827","type":"print"},{"value":"1435-165X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,5]]}}}